Literature DB >> 21307598

Characterization of a novel histone H3K36 methyltransferase setd3 in zebrafish.

Dong-Wook Kim1, Kee-Beom Kim, Ji-Young Kim, Sang-Beom Seo.   

Abstract

Post-translational modifications of histones have been demonstrated to play important roles in the regulation of chromatin structure and transcriptional regulation. In histone modification, methylated lysine has an important role in transcriptional regulation. The evolutionarily conserved SET domain was first identified in Drosophila proteins: Suppressor of variegation (Su(var)3-9), Enhancer of zeste (E(z)), and Trithorax. SET domain-containing proteins have histone methyltransferase (HMTase) activity via the SET domain. Using a bioinformatics approach, we identified and cloned zebrafish setd3 containing SET and Rubis-subs-bind domains. In this study, we report that setd3 had lysine specificity toward histone H3K36. Methylation of histone H3K36 is known as one of the transcriptional activation markers. It transiently transfected setd3 activated general transcription in reporter assays. Overexpression of setd3 decreased cell viability and activated caspase-3, indicating possible roles in apoptotic cell death and cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307598     DOI: 10.1271/bbb.100648

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  17 in total

Review 1.  Histone methyltransferases: novel targets for tumor and developmental defects.

Authors:  Xin Yi; Xue-Jun Jiang; Xiao-Yan Li; Ding-Sheng Jiang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.

Authors:  Xiaoqing Cheng; Yuan Hao; Wenjie Shu; Mengjie Zhao; Chen Zhao; Yuan Wu; Xiaodan Peng; Pinfang Yao; Daibiao Xiao; Guoliang Qing; Zhengying Pan; Lei Yin; Desheng Hu; Hai-Ning Du
Journal:  J Biol Chem       Date:  2017-04-25       Impact factor: 5.157

3.  Deletion of Mouse Setd4 Promotes the Recovery of Hematopoietic Failure.

Authors:  Xing Feng; Huimei Lu; Jingyin Yue; Megha Shettigar; Jingmei Liu; Lisa K Denzin; Zhiyuan Shen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-04       Impact factor: 7.038

4.  SETD3 protein is the actin-specific histidine N-methyltransferase.

Authors:  Sebastian Kwiatkowski; Agnieszka K Seliga; Didier Vertommen; Marianna Terreri; Takao Ishikawa; Iwona Grabowska; Marcel Tiebe; Aurelio A Teleman; Adam K Jagielski; Maria Veiga-da-Cunha; Jakub Drozak
Journal:  Elife       Date:  2018-12-11       Impact factor: 8.140

5.  Unmasking the mammalian SET domain-containing protein 4.

Authors:  Yuan Wang; Zhiyuan Shen
Journal:  NAR Cancer       Date:  2022-07-13

6.  The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.

Authors:  Zhangguo Chen; Catherine T Yan; Yali Dou; Sawanee S Viboolsittiseri; Jing H Wang
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

7.  Loss of Setd4 delays radiation-induced thymic lymphoma in mice.

Authors:  Xing Feng; Huimei Lu; Jingyin Yue; Neta Schneider; Jingmei Liu; Lisa K Denzin; Chang S Chan; Subhajyoti De; Zhiyuan Shen
Journal:  DNA Repair (Amst)       Date:  2019-11-25

8.  SETD4-mediated KU70 methylation suppresses apoptosis.

Authors:  Yuan Wang; Bochao Liu; Huimei Lu; Jingmei Liu; Peter J Romanienko; Gaetano T Montelione; Zhiyuan Shen
Journal:  Cell Rep       Date:  2022-05-10       Impact factor: 9.995

9.  A fluorescent bimolecular complementation screen reveals MAF1, RNF7 and SETD3 as PCNA-associated proteins in human cells.

Authors:  Simon E Cooper; Elsie Hodimont; Catherine M Green
Journal:  Cell Cycle       Date:  2015-06-01       Impact factor: 4.534

10.  SETD3 Downregulation Mediates PTEN Upregulation-Induced Ischemic Neuronal Death Through Suppression of Actin Polymerization and Mitochondrial Function.

Authors:  Xiangyu Xu; Yu Cui; Qi Wan; Qiang Wang; Congqin Li; Yuyang Wang; Jing Cheng; Songfeng Chen; Jiangdong Sun; Jinyang Ren; Xujin Yao; Jingchen Gao; Xiaohong Huang
Journal:  Mol Neurobiol       Date:  2021-07-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.